{"slideshow_credits": null, "snippet": "The agency\u2019s decision on generic Opana ER came just weeks after it reached the opposite conclusion in the case of another frequently abused painkiller, OxyContin.", "abstract": "Food and Drug Administration announces generic versions of painkiller Opana ER can remain on market, dealing blow to brand-name manufacturer Endo Health Solutions, which had asked agency to declare generic versions unsafe.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/05/11/business/endo-loses-bid-to-block-sales-of-generic-painkiller.html", "lead_paragraph": "The agency\u2019s decision on generic Opana ER came just weeks after it reached the opposite conclusion in the case of another frequently abused painkiller, OxyContin.", "headline": {"seo": "Endo Loses Bid to Block Sales of Generic Painkiller", "main": "F.D.A. Rejects Request to Block Sales of Generic Painkiller", "print_headline": "F.D.A. Rejects Request to Keep Generic Rivals of Painkiller Off the Market"}, "_id": "5190d2be40e9ec457e2a08de", "word_count": "392", "multimedia": [], "pub_date": "2013-05-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Endo Pharmaceuticals Holdings Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "2"}, {"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}